SCHEMBL17602018

SCHEMBL17602018

CNC(=O)c1cc(OC)c(OC)cc1Br

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.65
FYN P06241 1/20 0.65
PLK1 P53350 1/20 0.47
KDM4E B2RXH2 1/20 0.44
APAF1 O14727 1/20 0.44
TDP2 O95551 1/20 0.44
NSD2 O96028 1/20 0.44
CASP3 P42574 1/20 0.44
PPP1CA P62136 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
UBA2 Q9UBT2 1/20 0.44
LMNA P02545 1/20 0.44
KDM1A O60341 1/20 0.43
CYP3A4 P08684 2/20 0.43
HTT P42858 1/20 0.43
PRKDC P78527 1/20 0.43
ALDH1A1 P00352 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31649971 0.86 LCK (0.49) LCKFYNPLK1KDM4ELMNA
SCHEMBL2352873 0.84 LCK (0.46) LCKFYNPLK1LMNACYP3A4
SCHEMBL12682412 0.84 LCK (0.62) LCKFYNKDM4EAPAF1TDP2
SCHEMBL7954427 0.82 CYP3A4 (0.57) PLK1KDM4ELMNACYP3A4HTT
SCHEMBL12497066 0.81 LCK (0.69) LCKFYNKDM4EAPAF1TDP2
SCHEMBL29945757 0.81 LCK (0.69) LCKFYNKDM4EAPAF1TDP2
SCHEMBL2332823 0.81 LCK (0.59) LCKFYNKDM4EAPAF1TDP2
SCHEMBL2360957 0.81 LCK (0.59) LCKFYNKDM4EAPAF1TDP2
SCHEMBL27785704 0.80 LCK (0.74) LCKFYNKDM4EAPAF1TDP2
SCHEMBL22323973 0.80 KDM4E (0.51) LCKFYNPLK1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-24 US claimed
US-9682954-B2 Phenanthridine derivatives, preparation methods and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2017-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CTNNB1, WNT3A, WNT1 LCK 2299/4885FYN 1862/4885PLK1 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.